https://www.selleckchem.com/products/skl2001.html
Their 1-month follow-up left ventricular ejection fraction increased significantly (P less then 0.001). There were no deaths, and all patients were discharged from hospital with good quality of life. In contrast, all the eight patients receiving DFO monotherapy died (P less then 0.001). Accordingly, combined chelation therapy with high-dose L1 and DFO should be considered in patients with TDT presenting cardiac complications.Hematopoietic stem cell transplantation (HSCT) is a risk factor for viral hepatitis reactivations because it
Curtir
Comentario
Compartilhar
